Quantcast

Neuronetics prices IPO at $17, above the range


Shutterstock photo

Neuronetics, which sells a medical system that uses magnetic stimulation to relieve depression, raised $94 million by offering 5.5 million shares at $17, above the range of $14 to $16. Neuronetics plans to list on the Nasdaq under the symbol STIM. Piper Jaffray and William Blair acted as lead managers on the deal.

The article Neuronetics prices IPO at $17, above the range originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.



This article appears in: News Headlines , IPOs



More from Renaissance Capital

Subscribe






Renaissance Capital
Contributor:

Renaissance Capital

IPOs










Research Brokers before you trade

Want to trade FX?